Safety and Tolerability of Repetitive Transcranial Magnetic Stimulation During Pregnancy: A Case Report and Literature Review.


Journal

Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society
ISSN: 1537-1603
Titre abrégé: J Clin Neurophysiol
Pays: United States
ID NLM: 8506708

Informations de publication

Date de publication:
Mar 2020
Historique:
entrez: 7 3 2020
pubmed: 7 3 2020
medline: 14 7 2020
Statut: ppublish

Résumé

Patients with neuropsychiatric disease may benefit from repetitive transcranial magnetic stimulation as a nonpharmacologic alternative to relieve symptoms of major depression, obsessive compulsive disorder, and perhaps other syndromes such as epilepsy. We present a case of repetitive transcranial magnetic stimulation treatment as an adjunct therapy for a patient experiencing refractory epileptic seizures during the third trimester of pregnancy. Notably, the patient tolerated repetitive transcranial magnetic stimulation well, without adverse events, and delivered a healthy child. We also summarize the current literature pertaining to therapeutic repetitive transcranial magnetic stimulation use during pregnancy.

Identifiants

pubmed: 32142024
doi: 10.1097/WNP.0000000000000552
pii: 00004691-202003000-00008
doi:

Types de publication

Case Reports Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

164-169

Références

Sun W, Mao W, Meng X, et al. Low-frequency repetitive transcranial magnetic stimulation for the treatment of refractory partial epilepsy: a controlled clinical study. Epilepsia 2012;53:1782–1789.
Sun W, Fu W, Mao W, Wang D, Wang Y. Low-frequency repetitive transcranial magnetic stimulation for the treatment of refractory partial epilepsy. Clin EEG Neurosci 2011;42:40–44.
Kinoshita M, Ikeda A, Begum T, et al. Low-frequency repetitive transcranial magnetic stimulation for seizure suppression in patients with extratemporal lobe epilepsy—a pilot study. Seizure 2005;14:387–392.
Rotenberg A, Bae EH, Takeoka M, Tormos JM, Schachter SC, Pascual-Leone A. Repetitive transcranial magnetic stimulation in the treatment of epilepsia partialis continua. Epilepsy Behav 2009;14:253–257.
Rotenberg A, Depositario-Cabacar D, Bae EH, et al. Transient suppression of seizures by repetitive transcranial magnetic stimulation in a case of Rasmussen's encephalitis. Epilepsy Behav 2008;13:260–262.
Lefaucheur J-P, Picht T. The value of preoperative functional cortical mapping using navigated TMS. Neurophysiol Clin 2016;46:125–133.
Hannula H, Ilmoniemi RJ. Basic principles of navigated TMS. In: Navigated transcranial magnetic stimulation in neurosurgery. Switzerland: Springer International Publishing AG, 2017:3–29.
Damar U, Gersner R, Johnstone JT, et al. Alterations in the timing of Huperzine a cerebral pharmacodynamics in the acute traumatic brain injury setting. J Neurotrauma 2018;35:393–397.
Dhamne SC, Ekstein D, Zhuo Z, et al. Acute seizure suppression by transcranial direct current stimulation in rats. Ann Clin Transl Neurol 2015;2:843–856.
Hsieh TH, Lee HHC, Hameed MQ, Pascual-Leone A, Hensch TK, Rotenberg A. Trajectory of parvalbumin cell impairment and loss of cortical inhibition in traumatic brain injury. Cereb Cortex 2017;27:5509–5524.
Ziemann U. Pharmacology of TMS. Suppl Clin Neurophysiol 2003;56:226–231.
Pilato F, Profice P, Ranieri F, et al. Synaptic plasticity in neurodegenerative diseases evaluated and modulated by in vivo neurophysiological techniques. Mol Neurobiol 2012;46:563–571.
O'Reardon JP, Solvason HB, Janicak PG, et al. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry 2007;62:1208–1216.
Perera T, George MS, Grammer G, Janicak PG, Pascual-Leone A, Wirecki TS. The clinical TMS society consensus review and treatment recommendations for TMS therapy for major depressive disorder. Brain Stimul 2016;9:336–346.
Levkovitz Y, Isserles M, Padberg F, et al. Efficacy and safety of deep transcranial magnetic stimulation for major depression: a prospective multicenter randomized controlled trial. World Psychiatry 2015;14:64–73.
Loo CK, McFarquhar TF, Mitchell PB. A review of the safety of repetitive transcranial magnetic stimulation as a clinical treatment for depression. Int J Neuropsychopharmacol 2008;11:131–147.
Anderson B, Mishory A, Nahas Z, et al. Tolerability and safety of high daily doses of repetitive transcranial magnetic stimulation in healthy young men. J ECT 2006;22:49–53.
Rossi S, Hallett M, Rossini PM, Pascual-Leone A; Safety of TMS Consensus Group. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. 2009;120:2008–2039.
Di Iorio R, Rossini PM. Safety considerations of the use of TMS. In: Navigated transcranial magnetic stimulation in neurosurgery. Switzerland: Springer International Publishing AG, 2017:67–83.
Pereira LS, Müller VT, da Mota Gomes M, Rotenberg A, Fregni F. Safety of repetitive transcranial magnetic stimulation in patients with epilepsy: a systematic review. Epilepsy Behav 2016;57:167–176.
Bae EH, Schrader LM, Machii K, et al. Safety and tolerability of repetitive transcranial magnetic stimulation in patients with epilepsy: a review of the literature. Epilepsy Behav 2007;10:521–528.
Schrader LM, Stern JM, Koski L, Nuwer MR, Engel J. Seizure incidence during single- and paired-pulse transcranial magnetic stimulation (TMS) in individuals with epilepsy. Clin Neurophysiol 2004;115:2728–2737.
George MS, Wassermann EM, Williams WA, et al. Daily repetitive transcranial magnetic stimulation (rTMS) improves mood in depression. Neuroreport 1995;6:1853–1856.
Yanamadala J, Noetscher GM, Makarov SN, Pascual-Leone A. Estimates of peak electric fields induced by transcranial magnetic stimulation in pregnant women as patients using an FEM full-body model. Conf Proc IEEE Eng Med Biol Soc 2017;2017:1441–1444.
McRobbie D. Concerning guidelines for limiting exposure to time-varying electric, magnetic, and electromagnetic fields (1 Hz-100 khz). Health Phys 2010;99:818–836.
Dodick DW, Schembri CT, Helmuth M, Aurora SK. Transcranial magnetic stimulation for migraine: a safety review. Headache 2010;50:1153–1163.
Knoth RL, Bolge SC, Kim E, Tran QV. Effect of inadequate response to treatment in patients with depression. Am J Manag Care 2010;16:e188–e1896.
Clarke BM, Upton AR, Kamath MV, Al-Harbi T, Castellanos CM. Transcranial magnetic stimulation for migraine: clinical effects. J Headache Pain 2006;7:341–346.
Ko JY, Rockhill KM, Tong VT, Morrow B, Farr SL. Trends in postpartum depressive symptoms—27 states, 2004, 2008, and 2012. MMWR Morb Mortal Wkly Rep 2017;66:153.
Barth C, Villringer A, Sacher J. Sex hormones affect neurotransmitters and shape the adult female brain during hormonal transition periods. Front Neurosci 2015;9:37.
Bennett HA, Einarson A, Taddio A, Koren G, Einarson TR. Prevalence of depression during pregnancy: systematic review. Obstet Gynecol 2004;103:698–709.
Kim DR, O'Reardon JP, Epperson CN. Guidelines for the management of depression during pregnancy. Curr Psychiatry Rep 2010;12:279–281.
Payne JL, Meltzer-Brody S. Antidepressant use during pregnancy: current controversies and treatment strategies. Clin Obstet Gynecol 2009;52:469–482.
National Collaborating Centre for Mental Health (UK). Antenatal and postnatal mental health: Clinical management and service guidance: Updated edition: Leicester: British Psychological Society, 2014.
Nillni YI, Mehralizade A, Mayer L, Milanovic S. Treatment of depression, anxiety, and trauma-related disorders during the perinatal period: a systematic review. Clin Psychol Rev 2018;66:136–148.
Susser LC, Sansone SA, Hermann AD. Selective serotonin reuptake inhibitors for depression in pregnancy. Am J Obstet Gynecol 2016;215:722–730.
Pearlstein T. Depression during pregnancy. Best Pract Res Clin Obstet Gynaecol 2015;29:754–764.
Dennis CL, Dowswell T. Interventions (other than pharmacological, psychosocial or psychological) for treating antenatal depression. Cochrane Database Syst Rev 2013:Cd006795.
Ward HB, Fromson JA, Cooper JJ, De Oliveira G, Almeida M. Recommendations for the use of ECT in pregnancy: literature review and proposed clinical protocol. Arch Womens Ment Health 2018;21:715–722.
Leiknes KA, Cooke MJ, Jarosch-von Schweder L, Harboe I, Høie B. Electroconvulsive therapy during pregnancy: a systematic review of case studies. Arch Womens Ment Health 2015;18:1–39.
Bench CJ, Friston KJ, Brown RG, Scott LC, Frackowiak RS, Dolan RJ. The anatomy of melancholia: focal abnormalities of cerebral blood flow in major depression. Psychol Med 1992;22:607–615.
Dean B, Tawadros N, Scarr E, Gibbons AS. Regionally-specific changes in levels of tumour necrosis factor in the dorsolateral prefrontal cortex obtained postmortem from subjects with major depressive disorder. J Affect Disord 2010;120:245–248.
Koenigs M, Grafman J. The functional neuroanatomy of depression: distinct roles for ventromedial and dorsolateral prefrontal cortex. Behav Brain Res 2009;201:239–243.
Galynker II, Cai J, Ongseng F, Finestone H, Dutta E, Serseni D. Hypofrontality and negative symptoms in major depressive disorder. J Nucl Med 1998;39:608–612.
Pascual-Leone A, Rubio B, Pallardó F, Catalá MD. Rapid-rate transcranial magnetic stimulation of left dorsolateral prefrontal cortex in drug-resistant depression. Lancet 1996;348:233–237.
Pascual-Leone A, Hallett M. Induction of errors in a delayed response task by repetitive transcranial magnetic stimulation of the dorsolateral prefrontal cortex. Neuroreport 1994;5:2517–2520.
Nierenberg AA, DeCecco LM. Definitions of antidepressant treatment response, remission, nonresponse, partial response, and other relevant outcomes: a focus on treatment-resistant depression. J Clin Psychiatry 2001;62:5–9.
Macher JP, Crocq MA. Treatment goals: response and nonresponse. Dialogues Clin Neurosci 2004;6:83–91.
Nahas Z, Bohning DE, Molloy MA, Oustz JA, Risch SC, George MS. Safety and feasibility of repetitive transcranial magnetic stimulation in the treatment of anxious depression in pregnancy: a case report. J Clin Psychiatry 1999;60:50–52.
Klirova M, Novak T, Kopecek M, Mohr P, Strunzova V. Repetitive transcranial magnetic stimulation (rTMS) in major depressive episode during pregnancy. Neuro Endocrinol Lett 2008;29:69–70.
Zhang X, Liu K, Sun J, Zheng Z. Safety and feasibility of repetitive transcranial magnetic stimulation (rTMS) as a treatment for major depression during pregnancy. Arch Womens Ment Health 2010;13:369–370.
Tan O, Tarhan N, Coban A, et al. Antidepressant effect of 58 sessions of rTMS in a pregnant woman with recurrent major depressive disorder: a case report. Prim Care Companion J Clin Psychiatry 2008;10:69–71.
Kim DR, Epperson N, Paré E, et al. An open label pilot study of transcranial magnetic stimulation for pregnant women with major depressive disorder. J Womens Health (Larchmt) 2011;20:255–261.
Gahr M, Blacha C, Connemann BJ, Freudenmann RW, Schönfeldt-Lecuona C. Successful treatment of major depression with electroconvulsive therapy in a pregnant patient with previous non-response to prefrontal rTMS. Pharmacopsychiatry 2012;45:79–80.
Hizli Sayar G, MacMaster FP. Transcranial magnetic stimulation during pregnancy. Arch Womens Ment Health 2014;17:311–315.
Burton C, Gill S, Clarke P, Galletly C. Maintaining remission of depression with repetitive transcranial magnetic stimulation during pregnancy: a case report. Arch Womens Ment Health 2014;17:247–250.
Ferrao YA, da Silva RMF. Repetitive transcranial magnetic stimulation for the treatment of major depression during pregnancy. Rev Bras Psiquiatr 2018;40:227–228.
Guerrero Solano JL, Molina Pacheco E. Low-frequency rTMS Ameliorates akathisia during pregnancy. J Neuropsychiatry Clin Neurosci 2017;29:409–410.
Eryilmaz G, Sayar GH, Özten E. Follow-up study of children whose mothers were treated with transcranial magnetic stimulation during pregnancy: preliminary results. Neuromodulation 2015;18:255–260.
Kim DR, Sockol L, Barber JP, et al. A survey of patient acceptability of repetitive transcranial magnetic stimulation (TMS) during pregnancy. J Affect Disord 2011;129:385–390.

Auteurs

Ugur Damar (U)

Division of Epilepsy and Clinical Neurophysiology, Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, U.S.A.
Boston Children's Hospital, F.M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, Massachusetts, U.S.A.

Harper Lee Kaye (H)

Division of Epilepsy and Clinical Neurophysiology, Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, U.S.A.
Boston Children's Hospital, F.M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, Massachusetts, U.S.A.

Nicole A Smith (NA)

Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, U.S.A.

Page B Pennell (PB)

Division of Epilepsy, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, U.S.A.; and.

Alexander Rotenberg (A)

Division of Epilepsy and Clinical Neurophysiology, Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, U.S.A.
Boston Children's Hospital, F.M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, Massachusetts, U.S.A.
Berenson-Allen Center for Noninvasive Brain Stimulation, Department of Neurology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, U.S.A.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH